Business Context and Reporting Period
This Form 8-K Current Report was filed by Clarivate Plc on March 9, 2023. The filing primarily serves to disclose the Company's Investor Day conference held on the same date, during which management provided a business update and reaffirmed its full-year financial guidance for the fiscal year ending December 31, 2023.
Key Financial Metrics and Guidance
The filing does not contain historical financial results for the prior period but provides the following reaffirmed non-GAAP guidance for the full year 2023:
- Revenues: $2.63 billion to $2.73 billion
- Organic Revenue Growth: 2.75% to 3.75%
- Adjusted EBITDA: $1.10 billion to $1.16 billion
- Adjusted EBITDA Margin: 42.0% to 42.5%
- Adjusted Diluted EPS: $0.75 to $0.85 (based on approximately 740 million fully diluted weighted average shares)
- Free Cash Flow: $450 million to $550 million
The filing text does not provide specific values for total debt, liquidity positions, or GAAP net income for the current period.
Material Changes and Outlook
Clarivate reaffirmed the guidance previously announced on March 1, 2023. The outlook assumes no further acquisitions, divestitures, or unanticipated events. There are no material changes to the financial trajectory compared to the initial March 1 announcement.
Risks, Contingencies, and Management Commentary
Management highlighted several factors that could cause actual results to differ materially from the forward-looking statements, including:
- Success in integrating acquired businesses and realizing cost savings.
- Impact of inflation, foreign currency fluctuations, and the COVID-19 pandemic.
- International hostilities and governmental/regulatory investigations.
- Customer retention strategies and product development execution.
The filing includes standard disclaimers that forward-looking statements are based on current beliefs and assumptions and are not assurances of future performance.
Investor Verification Checklist
- Verify the reconciliation of non-GAAP measures (Adjusted EBITDA, Adjusted EPS) to GAAP measures in Exhibit 99.2.
- Review the Investor Day presentation (Exhibit 99.1) for detailed strategic context behind the reaffirmed guidance.
- Confirm the share count assumption of approximately 740 million fully diluted shares used for EPS calculations.
- Monitor for any updates regarding the "unanticipated events" or M&A activity that the guidance explicitly excludes.